Another review found a significant treatment effect for constraint-induced movement therapy (CIMT) in only 1 trial based on an assessment of bimanual use. 3 A positive trend favoring CIMT was shown in 2 other studies, and it was recommended that the approach receive further investigation. 3 Another systematic review that investigated UL BoNT-A injections for children with CP was inconclusive. 4 Together these reviews highlighted the need to evaluate UL function by using objective, reliable, and valid measures in future studies. In subsequent years, results of other randomized, controlled trials (RCTs) have been published. In addition, new interventions such as hand-arm bimanual intensive training (HABIT) 5 have emerged.
Considering the broad range of interventions, relative cost, and time commitment, it is timely to evaluate the efficacy of all therapeutic UL interventions. Of particular interest is their impact on UL activity performance and how this might translate into the broader context of participation in home, school, and community life. The aim of this systematic review was to determine the efficacy of UL interventions for children with congenital hemiplegia (aged 0 -18 years) on activity and participation outcomes compared with no intervention or standard care.
Eligibility for study inclusion was assessed independently by 2 reviewers (Ms Sakzewski and Dr Boyd). The initial search yield was reviewed by Ms Sakzewski on the basis of title and abstract. The full text of the articles that adhered to the inclusion criteria was then assessed by both reviewers.
Data Extraction
Details of study methodology and population were summarized for all trials (Table 1 ) and systematic reviews ( Table 2 ). Methodologic quality of the included trials was evaluated by using the PEDro (Physiotherapy Evidence Database) scale (Table 3) . 6, 7 The scale has 11 criteria, each scored as 0 or 1, resulting in a possible total of 11 points. Interrater reliability of the PEDro scale is adequate. 8 Two reviewers (Ms Sakzewski and Dr Boyd) independently assessed methodologic quality. Studies with scores of Ն5 were regarded as having adequate internal validity and, therefore, were included in the meta-analysis. 8 Methodologic quality of the included systematic reviews was assessed by using the Assessment of Multiple Systematic Reviews (AMSTAR) ( Table 4) . 9 A score of 1 was recorded for each criterion present, with a total possible score of 11. The AMSTAR has good face and content validity. 9 Data Synthesis RevMan 5.0 (Cochrane Collaboration, Oxford, England) was used for data management and analysis. Outcomes with continuous measurement scales were summarized for each study by using means, effect sizes (ESs), and 95% confidence intervals (CIs) for treatment and control groups. ESs of 0.2 were considered small, 0.4 to 0.6 moderate, and 0.8 large. 10 For meta-analysis, for comparison between treatment and control groups for continuous measurement scales, standardized mean differences (SMDs) with 95% CIs were calculated. A fixed-effect model was used to pool treatment effects when trials used similar outcome measures on similar populations. 11 Heterogeneity was evaluated by using the I 2 statistic, with larger percentage scores representing greater heterogeneity. 12 
RESULTS

Description of Studies
The search strategy yielded 177 unique references. Twenty RCTs and 8 systematic reviews of therapeutic UL interventions met inclusion criteria and were examined by 2 independent reviewers. [2] [3] [4] [5] Seven trials and 1 systematic review were excluded 13, [31] [32] [33] [34] [35] [36] ; reasons for the exclusion are listed in Fig 1. Two articles reported the same study. 22, 24 
Study Participants
Seven trials specifically targeted 222 children with congenital hemiplegia. 5, [17] [18] [19] 21, 25 Five studies had a broader sample of 176 children with CP that included a subset of children with hemiplegia. 14, 15, 20, 22, 24 One study consisted predominantly of children with hemiplegia and 2 subjects with different distributions of CP. 16 The age range of children differed across trials, ranging from 18 months to 16 years.
Types of Intervention
Four broad categories of intervention were identified: NDT, 14,15 CIMT 22, 24, 25 and forced-use therapy, 23 HABIT, 5 and intramuscular BoNT-A injections to the UL with or without therapy. [16] [17] [18] [19] [20] [21] Details of the intervention programs are summarized in Table 5 . Five identified systematic reviews included some trials identified in this current review. Two systematic reviews evaluated BoNT-A injections to the UL 4, 29 . The first included 2 RCTs 16,17 and the second reported on 3 RCTs. [16] [17] [18] A systematic review of CIMT 3 identified 1 RCT and 1 quasi-RCT of 49 subjects. 23, 24 A systematic review evaluating OT 28 identified 2 RCTs of NDT 14, 15 included in this review. Further review of systematic reviews 29 identified the same 2 RCTs evaluating UL casting 14, 15 but did not find any RCTs of UL splinting. Our review has identified another 5 RCTs across UL interventions.
Study Design
All included studies were RCTs that compared an intervention to a control group that received either no inter-
FIGURE 1
Results of search strategy of UL systematic review. a Two articles reported the same study. 22, 24 Scale of item score: 0, absent; 1, present. The PEDro scale criteria are (1) specified eligibility criteria; (2) random allocation; (3) concealed allocation; (4) similarity at baseline on key measures; (5) subject blinding; (6) therapist blinding; (7) assessor blinding; (8) Ͼ85% follow-up of at least 1 key outcome; (9) intention-to-treat analysis; (10) between-group statistical comparison for at least 1 key outcome; and (11) point estimates and measures of variability provided for at least 1 key outcome. Scale of item score: 0, absent; 1, present. The AMSTAR criteria are (1) a priori design; (2) duplicate study selection and data extraction; (3) comprehensive literature search; (4) inclusive publication status; (5) included/excluded studies provided; (6) characteristics of included studies provided; (7) quality assessment of studies; (8) study quality used appropriately in formulating conclusions; (9) appropriate methods used to combine studies; (10) publication bias assessed; and (11) conflict of interest stated. 
Types of Outcome Measures
A range of standardized and nonstandardized assessments was used across the studies. These could be grouped into assessments of UL function, self-care, and individualized outcomes. No studies reported outcomes measuring participation.
Adverse Events
Minor adverse events included nausea and vomiting 20, 21 and transient weakness after BoNT-A injections. 16, 17, 21 These events were short-acting and reversible. Minor skin irritations as a result of casting were reported in 3 cases of CIMT, along with behavioral problems that preexisted the intervention. 24 In general, there was high retention within studies; however, Wallen et al 20 and Law et al 14 reported 6 of 80 and 6 of 79 cases, respectively, that did not proceed because of dissatisfaction with group allocation.
Qualitative Assessment
All included trials had moderate-to-high quality, scoring Ն5 on the PEDro scale (Table 1) . Three studies did not have adequate data for meta-analysis. 16, 18, 24 One study reported median scores, 18 1 reported median scores on nonstandardized assessments, 16 and 1 reported summary statistics. 24 Quality scores of the RCTs are presented in Table 3 , and systematic reviews are shown in Table 4 .
Primary Outcome: UL Function
Results of studies reporting on UL outcomes are summarized in Table 6 . All meta-analyses are summarized in Figs 2 and 3. Two outcome measures for UL function had sufficient data to be pooled for meta-analysis in trials of NDT and intramuscular BoNT-A. Children who received NDT and casting (n ϭ 88) compared with a control group that received regular OT or regular NDT (n ϭ 84) scored an SMD of 0.4 (95% CI: 0.10 to 0.71; P ϭ .009) on the Quality of Upper Extremity Skills Test (QUEST). 14, 15 The same groups were compared on the Peabody Fine Motor Scales (PFMS) and achieved an SMD (fixed) of 0.15 (95% CI: Ϫ0.15 to 0.45; P ϭ .34). Children who received BoNT-A injections and UL training (n ϭ 51) compared with a control group that received UL training (n ϭ 48) achieved an SMD (fixed) of 0.41 (95% CI: 0.00 to 0.81; P ϭ .05) on the QUEST. 17, 19, 20 
Achievement of Individualized Goals
Results of studies reporting on individualized outcomes are summarized in Table 7 . Data pooled from 2 studies 19, 20 that compared BoNT-A and OT (n ϭ 60) and control groups receiving OT or regular care (n ϭ 53) received an SMD of 0.44 (95% CI: Ϫ0.11 to 0.99; P ϭ .12) for Canadian Occupational Performance Measure (COPM) performance and an SMD of 0.48 (95% CI: 0.11 to 0.86; P ϭ .01) for COPM satisfaction. Goal Attainment Scale (GAS) scores were pooled from 3 studies that compared BoNT-A and OT (n ϭ 81) and control groups that received OT or regular care (n ϭ 75) with an SMD of 0.95 (95% CI: 0.62 to 1.29; P Ͻ .0001). [19] [20] [21] Self-care Outcomes Results of studies reporting self care outcomes are summarized in Table 8 . Pediatric Evaluation of Disability Inventory (PEDI) self-care scores were pooled from 2 studies 20,21 that compared BoNT-A and OT (n ϭ 60) with a control group that received OT (n ϭ 54) with an SMD of Ϫ0.03 (95% CI: Ϫ0.74 to 0.68; P ϭ .94).
DISCUSSION
With this systematic review we aimed to evaluate the efficacy of nonsurgical therapeutic UL interventions compared with no treatment or standard care on activity and participation outcomes for children with congenital hemiplegia. Thirteen RCTs and 7 systematic reviews met the a priori inclusion criteria.
Four intervention approaches were identified: (1) NDT; (2) UL BoNT-A injections combined with training; (3) CIMT; and (4) HABIT. Two of the approaches broadly target deficits of body structure and function (NDT and BoNT-A), and 2 focus on improving activity limitations (CIMT and HABIT). NDT remains a commonly used approach that aims to improve motor skills by reducing underlying impairments and facilitation of more normal movement patterns. 37, 38 Meta-analyses of NDT and casting yielded a medium treatment effect for quality of UL movement (QUEST) and a small effect to improve acquisition of fine motor skills (PFMS). 14, 15 The QUEST is predominantly an impairment-based measure with a small number of items that address activity performance; therefore, improvements in results may reflect gains in range of motion and biomechanical alignment as a result of casting. The 2 studies targeted different age groups; therefore, varied results may suggest that older children could have a greater response to casting and intensive NDT than younger children. Individualized goals (COPM) demonstrated the greatest change with NDT, 15 which could suggest that UL training, regardless of type or intensity, directed toward achievement of goals that are meaningful to the child and family may result in significant changes in parental perception of their child's performance. Another approach that targets body structure and function is BoNT-A injections. However, when used as an adjunct to UL training, activity-level change was addressed. Six RCTs investigated UL BoNT-A injections. With the exception of the double-blind RCT study by Corry et al 16 and a comparison by Wallen et al, 20 the remaining studies combined BoNT-A injections with UL training. The therapy accompanying BoNT-A injections varied across trials for duration (4 weeks to 6 months) and frequency (fortnightly to 3 times per week), giving a range in total dose of 4 to 12 hours. Data pooled from 3 studies yielded only a small treatment effect for BoNT-A and UL training compared with a control group to improve quality of movement (QUEST). This is not surprising, considering the control groups received UL training that was equivalent to that of the intervention groups in 3 studies. 17, 19, 20 These results suggest that UL training alone is effective in improving quality of UL movement, but BoNT-A provides a consistent supplementary effect to UL training.
The efficacy of BoNT-A in achieving individualized outcomes was moderately supported when using a validated tool, the COPM, and strongly supported with the GAS. A sizeable treatment effect favoring BoNT-A was evident in 3 studies that reported GAS outcomes. [19] [20] [21] Pooled data from 3 studies achieved a moderate treatment effect for BoNT-A (n ϭ 60) compared with the control group (n ϭ 53) on COPM performance and satisfaction. 19, 20 Two other interventions focus on either a unimanual or bimanual approach to UL training. With CIMT, a variety of constraints to the impaired limb (eg, plaster cast, mitt, sling, and manual restraint) are used. The accompanying intensive training of the impaired limb involves either shaping of targeted UL movements 25 or entire task practice, which is activity based. 33 Alternatively, HABIT mirrors the intensity of CIMT but targets intensive training of bimanual functional activities. Both CIMT and HABIT are underpinned by theories of motor learning and neuroplasticity; however, one relies on facilitating use-dependent reorganization due to intensive training of the impaired limb, and the other uses bimanual coordination and the unaffected hand to model motor control in the impaired hand. 22, 39 CIMT has generally been reported as a high-intensity intervention with a total dosage of intervention ranging from 60 to 126 hours. Alternatively, forced-use therapy involves immobilization of the unimpaired arm in a cast for 6 weeks accompanied by a total dose of 6 hours of therapy. 23 Preliminary results could suggest that CIMT not only contributes to improved efficiency and quality of UL movement but also increases spontaneous use of the involved limb in daily activity. Modified CIMT resulted in small treatment effect for improvements in UL movement efficiency (Jebsen Taylor Test of Hand Function) and moderate ESs to improve UL speed and dexterity (Bruininks-Oseretsky Test of Motor Proficiency [BOTMP]). 25 CIMT resulted in a large treatment effect for the development of new UL motor skills and an increased amount of use of the impaired limb. 22 However, these results should be viewed with caution, because many of the outcome measures used (eg, Pediatric Motor Activity Log, Emerging Behavior Scale, Caregiver Functional Use Survey, and selected items of the BOTMP) have no reported reliability or validity in children with congenital hemiplegia. 40 Furthermore, control groups in the studies continued with varying types of standard care. It is unclear whether improvement reported for the intervention group was product of CIMT or reflected a response to a higher intensity of intervention.
The 1 RCT that investigated HABIT showed a small treatment ES for bimanual performance when using a validated tool, the Assisting Hand Assessment. 5 How- ever, there were no improvements in unimanual speed and dexterity. For CIMT and HABIT, small samples and major baseline differences between groups are major limitations. Furthermore, it is unclear whether the constraint is essential and what type and intensity of training will best achieve improvements in activity limitations. Additional research is required to differentiate the effects of an intensive unimanual approach (eg, CIMT) compared with a bimanual approach (eg, HABIT). Acceptability and feasibility of any intervention is an important consideration. A number of minor adverse events were reported for BoNT-A that were short-acting and reversible. Very few adverse events were reported for CIMT or forced-use therapy. It could be reasonably expected that restraint of an unimpaired limb for such extended time might lead to frustration and have behavioral consequences. Most studies reported that participants adapted quickly to constraint with minimal difficulties encountered, with the exception of 1 child with behavior difficulties. 24 Adherence to intervention can be considered in terms of attendance at face-to-face sessions in addition to completion of home programs. In general, attendance at NDT and casting sessions was relatively high and varied with a mean of twenty-four 45-minute sessions of a possible 32 sessions (75%). 15 In addition, home programs were expected to be performed for 30 minutes/ day over the 120-day intervention period. However, parents fully completed the 30-minute program, on average, for 40 (40%) of the possible 120 days or partially completed the program, on average, for 22 (18%) of 120 days. Adherence to home programs in CIMT was 57% during the intervention period and 52% in the month after intervention, 25 with similar rates reported for HABIT. 26 Not all studies reported whether home programs were provided or adhered to. Home programs provided an additional dosage of intervention apart from the face-to-face sessions, and the relatively small rates of completion may raise the question of whether an adequate dosage of intervention was received. It was suggested recently that completion of home programs may depend on a goal-directed approach or on the duration of intervention. 41 A number of limitations exist with the current evidence for UL interventions. Small sample size in a number of studies has contributed to baseline inequality between intervention and control groups in 4 studies. 5, 18, 20, 25 Interpretation of ESs for these studies, therefore, needs to be considered with caution. Variable protocols of treatment intensity and duration across studies make comparison both between interventions and across the differing models of intervention difficult. Inconsistent use of outcome measures across trials or use of assessments with no reported validity or reliability for children with CP is problematic. Evaluation using individualized outcome measures is useful, given the heterogenous nature of the population, and should be considered in future UL intervention trials. Additional RCTs of adequate power are required particularly for CIMT and HABIT using reliable and valid instrumentation.
In this review we have highlighted that the strength of any 1 approach over the others is not clearly evident. There are promising consistent effects of BoNT-A supplementing various UL training approaches and interesting effects for CIMT and HABIT. Pooling data from larger RCTs could give an indication of the best responders (eg, impact of age, sensory deficits, differences between unimanual capacity and bimanual performance at baseline). Furthermore, the minimum dosage required to gain a treatment effect for any of the reviewed interventions remains unclear. In addition, the type of training accompanying BoNT-A needs to be investigated further. As yet, no intensive training approach has demonstrated sufficient additional treatment effect over and above-mentioned supplementary injections of BoNT-A and UL training.
RESEARCH IMPLICATIONS
The relationship between the nature of the structural brain lesion or corticospinal (re)organization in CP and the response to UL interventions for children with congenital hemiplegia has only been reported in 1 prospective study. 42 Additional RCTs investigating this relationship are required. The characteristics of best responders to the different interventions have not been reported to date.
CONCLUSIONS
Interventions that address UL dysfunction in children with hemiplegia are varied. There is growing evidence that BoNT-A supplements UL, training particularly toward the achievement of individualized goals. There remain limited high-level studies of NDT. CIMT and HABIT are emerging interventions; however, additional RCTs are required. Effective use of the UL affects on all aspects of daily life. Additional, suitably powered RCTs using valid and reliable outcome measures are required to determine the efficacy of UL interventions. Investigation of the minimum dosage of interventions to exact a treatment effect is required to optimize the investment of time and resources for service providers and for children with congenital hemiplegia and their families.
